Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents
US9504671B2 · kind B2 · utility
4Cited by
50References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 25, 2011 |
| Grant date | Nov 29, 2016 |
| Priority date | — |
| Expiry date | Nov 24, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention is directed to pharmaceutical compositions for topical administration to a mammal, wherein the pharmaceutical compositions comprise a spiro-oxindole compound, as an enantiomer, a racemate or a non-racemic mixture, or a pharmaceutically acceptable salt thereof. These pharmaceutical compositions are useful for the treatment and/or prevention of sodium channel-mediated diseases or conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.